Castle Biosciences Inc (CSTL)
Castle Biosciences - New Data at DDW 2026 ShowTissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barretts Esophagus
Castle Biosciences - New Data at DDW 2026 ShowTissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barretts Esophagus
📉 **NEGATIVE** • Medium confidence analysis (70%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General